Email Updates

You are here

Home

13 SEPTEMBER 2019 VOLUME 20 ISSUE 35

Media Coverage

  • Gay ‘Chemsex’ Is Fuelling Urban HIV Epidemics, AIDS Experts Warn

    A surge in “chemsex” parties, where people spend days getting high on drugs and having sex with scores of partners, is re-fuelling epidemics of HIV among gay men in European towns and cities, doctors say.

    September 12, 2019
    General
    Reuters

  • PrEP Is Reducing HIV Diagnoses in US Cities, Independently of the Effect of Treatment

    A study that compared pre-exposure prophylaxis (PrEP) usage rates in 19 US cities with the rates of HIV diagnosis has found that the cities with the highest rates of PrEP use in at-risk people had nearly 16 percent fewer diagnoses than the cities with the lowest rates, after adjusting for the proportion of people with HIV on treatment with suppressed viral loads.

    September 12, 2019
    PrEP
    aidsmap

  • Bundling PrEP With Family Planning May Be Key to HIV Prevention

    While much attention is paid to the risks of HIV in men who have sex with men—the most heavily impacted demographic in the United States —in less developed nations such as those in Africa, there exists an outsize risk of HIV infection in young women. Reaching this population is a priority for infectious disease specialists, who are working to increase the use of pre-exposure prophylaxis (PrEP) in this vulnerable group. One way to do that may be to bundle PrEP with birth control offerings in family planning clinics so as to increase uptake.

    September 12, 2019
    PrEP
    Contagion Live

  • Scientists Use Gene-Edited Stem Cells to Treat HIV — With Mixed Success

    Scientists in China engineered human stem cells to mimic a rare form of natural immunity to the virus and transplanted them into a man with HIV and blood cancer. The gene-edited cells survived in the man’s body for more than a year without causing detectable side effects, but the number of cells was not high enough to significantly reduce the amount of HIV in his blood.

    September 11, 2019
    General
    Nature

  • If We Want To Eliminate HIV, We Can't Ignore Women

    With reports earlier this year purporting of a second person having achieved complete HIV eradication (although experts cautioned it is way too early to declare the subject “cured”), the global scientific community is working harder than ever to find a functional cure for the virus. In order to do so, researchers are beginning to realize they have to deal with a long-ignored demographic: women.

    September 10, 2019
    General
    HIV Plus Mag

  • How 2020 Democrats Would End the HIV Epidemic

    With the third Democratic primary debate likely to bring the focus back to health care, nuances, six candidates have paid extra attention to combating the HIV epidemic, putting forward plans that rely heavily on expanding medical access across the country. AIDS United, a non-profit organization working to end the HIV epidemic in the United States, sent a questionnaire to every candidate running for president to increase awareness of the HIV issue, which is of global urgency. In the United States, over one million people are living with HIV.

    September 10, 2019
    General
    Daily Beast

  • HIV Still Number One Cause of Death in Zambia-Study

    A joint study by researchers from the International Institute of Applied Systems and Analysis, the University of the Witwatersrand and the University of Zambia has shown that HIV remains the leading cause of death in Zambia. This is despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago.

    September 10, 2019
    General
    Lusaka Times

  • HIV Statistics: What Are the Current Numbers?

    Today, AIDS is fairly well controlled – in developed countries anyway. But the virus, which actually has been infecting humans since at least 1959, and perhaps since the late 1940s, according to the AIDS Institute, is still very much around. Statistics compiled from a variety of sources by AmfAR, the Foundation for AIDS Research, paint an important picture of HIV/AIDS’s global and U.S. reach – showing where progress has been made, as well as where infections continue to rise.

    September 10, 2019
    General
    US News & World Report

  • Microneedle Patches Could Provide the Long-Acting HIV Treatment of the Future

    With long-acting injectable antiretroviral (ARV) treatment for HIV on the cusp of a likely approval, researchers are fast at work on the subsequent generations of technologies that deliver long-acting treatment or prevention of the virus. Investigators are, for example, developing a matchstick-sized implant that could deliver ARVs for up to 12 months.

    September 10, 2019
    Treatment
    POZ

  • At HIV Conference, London Mayor Calls for Broad Access to PrEP

    London Mayor Sadiq Khan called for broader availability of the HIV prevention method pre-exposure prophylaxis, or PrEP, as he welcomed leaders from 300 cities from around the world today for the opening of Fast-Track Cities 2019, a first-of-its-kind conference on municipal responses to HIV, tuberculosis, and viral hepatitis.

    September 9, 2019
    PrEP
    Advocate

  • Byanyima Takes Office in November

    “We expect Byanyima to take up her position with UNAIDS in November,” the agency's communications manager, Michael Hollingdale, told New Vision on Saturday. Hollingdale, however, said they did not have an exact start date for the outgoing Oxfam International executive director.

    September 7, 2019
    General
    New Vision

Published Research

Announcements